Benzinga | Jan 28, 2022 04:36AM EST

Keybanc Maintains Overweight on Teradyne, Lowers Price Target to $140

Keybanc analyst Steve Barger maintains Teradyne (NASDAQ:TER) with a Overweight and lowers the price target from $180 to $140.